Rating History for Salix Pharmaceuticals (SLXP) by RBC Capital

More Stocks Rated by RBC Capital | Latest Ratings for SLXP
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/11/2013 N/A New Coverage Outperform
(N/A)		 53.00
(N/A)		 45.59
(172.81)		 279.05% Details